高级检索

具有多靶点抗阿尔茨海默病活性的黄酮类化合物研究进展

Research advances of multi-targeted flavonoids in the intervention of Alzheimer′s disease

  • 摘要: 阿尔茨海默病(AD)是一种多见于老年人的慢性神经系统变性疾病,给家庭和社会带来了沉重的负担。现有的AD治疗药物仅能短期内改善AD的症状,并不能有效阻止和逆转该病的进程。鉴于AD病因复杂,同时作用于多个AD相关靶点的单一化合物,即“多靶点导向药物”将是AD药物研发的重要方向。黄酮类化合物在自然界广泛存在,具有多种药理活性,值得进一步开发。根据公开发表的文献,对多靶点抗阿尔茨海默病药物黄酮类化合物进行了总结,以期为多靶点抗AD药物的研发提供重要理论依据。

     

    Abstract: Alzheimer′s disease(AD)is a chronic progressive neurodegenerative disease in the elderly, which causes heavy burden for the society and family. The current drugs could only improve the cognitive symptoms in the short term, but could not reverse or stop the disease progression. In view of the complexity of AD, multi-targeted drugs could be a potential strategy for the treatment of AD. Flavonoids, widely exising in the natural world, have multiple pharmacological activities. This paper summarizes flavonoids as promising multi-targeted anti-AD candidates according to the reported references previonsly published, which could provide important evidences in the development of anti-AD durgs.

     

/

返回文章
返回